Viable Mouse Models of Acid β-Glucosidase Deficiency: The Defect in Gaucher Disease

American Journal of Pathology

Volumn 163, Issue 5, 2003, Pages 2093-2101

  Xu, You Hai ^a   Quinn, Brian ^a   Witte, David ^a   Grabowski, Gregory A ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; LIPID; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; ENZYME ACTIVITY; ENZYME DEFICIENCY; FIBROBLAST; GAUCHER DISEASE; HISTOPATHOLOGY; HOMOZYGOSITY; LIVER; LIVER SINUSOID; LUNG; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POINT MUTATION; PRIORITY JOURNAL; SPLEEN;

EID: 0142244182     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63566-3     Document Type: Article

References (45)

1. Beutler E, Grabowski GA: Gaucher disease. The Metabolic and Molecular Bases of Inherited Diseases. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York, McGraw-Hill, 2001, pp 3635-3668
2. Blom S, Erikson A: Gaucher disease-Norrbottnian type: neurodevelopmental, neurological, and neurophysiological aspects. Eur J Pediatr 1983, 140:316-322
3. Kolodny EH, Ullman MD, Mankin HJ, Raghavan SS, Topol J, Sullivan JL: Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients. Prog Clin Biol Res 1982, 95:33-65
4. Volk BW, Wallace BJ, Adachi M: Infantile Gaucher's disease: electron microscopic and histochemical studies of a cerebral biopsy. J Neuropathol Exp Neurol 1967, 26:176-177
5. Adachi M, Wallace BJ, Schneck L, Volk BW: Fine structure of central nervous system in early infantile Gaucher's disease. Arch Pathol (Chicago) 1967, 83:513-526
6. Charrow J, Andersson HC, Kaplan P, Kolodny E, Mistry PK, Pastores G, Rosenbloom B, Scott CR, Wappner RS, Weinreb N, Zimran A: The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 2000, 160:2835-2843
7. Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA: Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet 1993, 52:1094-1101
8. Abrahamov A, Elstein D, Gross-Tsur V, Farber B, Glaser Y, Hadas-Halpern I, Ronen S, Tafakidi M, Horowitz M, Zimran A: Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet 1995, 346:1000-1003
9. Theophilus B, Latham T, Grabowski GA, Smith FI: Gaucher disease: molecular heterogeneity and phenotype-genotype correlations. Am J Hum Genet 1989, 45:212-225
10. Theophilus BD, Latham T, Grabowski GA, Smith FI: Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid β-glucosidase gene. Nucleic Acids Res 1989, 17:7707-7722
11. Grace ME, Newman KM, Scheinker V, Berg-Fussman A, Grabowski GA: Analysis of human acid β-glucosidase by site-directed mutagenesis and heterologous expression. J Biol Chem 1994, 269:2283-2291
12. Sidransky E, Tayebi N, Stubblefield BK, Eliason W, Klineburgess A, Pizzolato GP, Cox JN, Porta J, Bottani A, DeLozier-Blanchet CD: The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease. J Med Genet 1996, 33:132-136
13. Finn LS, Zhang M, Chen SH, Scott CR: Severe type II Gaucher disease with ichthyosis, arthrogryposis, and neuronal apoptosis: molecular and pathological analyses. Am J Med Genet 2000, 91:222-226
14. Tayebi N, Cushner SR, Kleijer W, Lau EK, Damschroder-Williams PJ, Stubblefield BK, Den Hollander J, Sidransky E: Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene. Am J Med Genet 1997, 73:41-47
15. Tybulewicz VLJ, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK, Winfield S, Zablocka B, Sidransky E, Martin BM, Huang SP, Mintzer KA, Westphal H, Mulligan RC, Ginns EI: Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 1992, 357:407-410
16. Liu Y, Suzuki K, Reed JD, Grinberg A, Westphal H, Hoffmann A, Doring T, Sandhoff K, Proia RL: Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. Proc Natl Acad Sci USA 1998, 95:2503-2508
17. Kyle JW, Birkenmeier EH, Gwynn B, Vogler C, Hoppe PC, Hoffmann JW, Sly WS: Correction of murine mucopolysaccharidosis VII by a human β-glucuronidase transgene. Proc Natl Acad Sci USA 1990, 87:3914-3918
18. Vogler C, Birkenmeier EH, Sly WS, Levy B, Pegors C, Kyle JW, Beamer WG: A murine model of mucopolysaccharidosis VII: gross and microscopic findings in β-glucuronidase-deficient mice. Am J Pathol 1990, 136:207-217
19. Sands MS, Barker JE, Vogler C, Levy B, Gwynn B, Galvin N, Sly WS, Birkenmeier E: Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest 1993, 68:676-686
20. Clarke LA, Russell CS, Pownall S, Warrington CL, Borowski A, Dimmick JE, Toone J, Jirik FR: Murine mucopolysaccharidosis type I: targeted disruption of the murine α-L-iduronidase gene. Hum Mol Genet 1997, 6:503-511
21. de Geest N, Bonten E, Mann L, de Sousa-Hitzier J, Hahn C, d'Azzo A: Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet 2002, 11:1455-1464
22. Marathe S, Miranda SR, Devlin C, Johns A, Kuriakose G, Williams KJ, Schuchman EH, Tabas I: Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function. Hum Mol Genet 2000, 9:1967-1976
23. Li CM, Park JH, Simonaro CM, He X, Gordon RE, Friedman AH, Ehleiter D, Paris F, Manova K, Hepbildikler S, Fuks Z, Sandhoff K, Kolesnick R, Schuchman EH, Hepbiloikler S: Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics 2002, 79:218-224
24. Sandhoff K, Kolter T, Harzer K: Sphingolipid activator proteins. The Metabolic and Molecular Bases of Inherited Disease. Edited by Scriver CR, Beaudet A, Sly W, Valle D. New York, McGraw-Hill, 2001, pp 3371-3388
25. Dahl N, Lagerström M, Erikson A, Pettersson U: Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet 1990, 47:275-278
26. Lewis BD, Nelson PV, Robertson EF, Morris CP: Mutation analysis of 28 Gaucher disease patients: the australasian experience. Am J Med Genet 1994, 49:218-223
27. O'Neill RR, Tokoro T, Kozak CA, Brady RO: Comparison of the chromosomal localization of murine and human glucocerebrosidase genes and of the deduced amino acid sequences. Proc Natl Acad Sci USA 1989, 86:5049-5053
28. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning, A Laboratory Manual. New York, Cold Spring Harbor Laboratory, 1989
29. Sabath DE, Broome HE, Prystowsky MB: Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 1990, 91:185-191
30. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York, Greene Publishing Associates and Wiley-Interscience, 1992, pp 10.5.1-10.5.5
31. Fabbro D, Desnick RJ, Grabowski GA: Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting. Am J Hum Genet 1987, 40:15-31
32. O'Reilly DR, Miller LK, Luckow VA: Baculovirus Expression Vectors: A Laboratory Manual. New York, W. H. Freeman and Company, 1992
33. Grabowski GA, Osiecki-Newman K, Dinur T, Fabbro D, Legler G, Gatt S, Desnick RJ: Human acid β-glucosidase: use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes. J Biol Chem 1986, 261:8263-8269
34. Fujita N, Suzuki K, Vanier MT, Popko B, Maeda N, Klein A, Henseler M, Sandhoff K, Nakayasu H: Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet 1996, 5:711-725
35. Wells MA, Dittmer JC: The use of Sephadex for the removal of non-lipid contaminants from lipid extracts. Biochemistry 1963, 2:1259-1263
36. Dreyfus H, Guerold B, Freysz L, Hicks D: Successive isolation and separation of the major lipid fractions including gangliosides from single biological samples. Anal Biochem 1997, 249:67-78
37. Igisu H, Takahashi H, Suzuki K, Suzuki K: Abnormal accumulation of galactosylceramide in the kidney of twitcher mouse. Biochem Biophys Res Commun 1983, 110:940-944
38. Daniels LB, Coyle PJ, Glew RH, Radin NS, Labow RS: Brain glucocerebrosidase in Gaucher's disease. Arch Neurol 1982, 39:550-556
39. Mizukami H, Mi Y, Wada R, Kono M, Yamashita T, Liu Y, Werth N, Sandhoff R, Sandhoff K, Proia RL: Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest 2002, 109:1215-1221
40. Sauer B: Inducible gene targeting in mice using the Cre/Iox system. Methods 1998, 14:381-392
41. Conzelmann E, Sandhoff K: Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci 1983, 6:58-71
42. Svennerholm L, Hakansson G, Mansson JE, Nilsson O: Chemical differentiation of the Gaucher subtypes. Prog Clin Biol Res 1982, 95:231-252
43. Conradi NG, Sourander P, Nilsson O, Svennerholm L, Erikson A: Neuropathology of the Norrbottnian type of Gaucher disease: morphological and biochemical studies. Acta Neuropathol (Berl) 1984, 65:99-109
44. Pasmanik-Chor M, Laadan S, Elroy-Stein O, Zimran A, Abrahamov A, Gatt S, Horowitz M: The glucocerebrosidase D409H mutation in Gaucher disease. Biochem Mol Med 1996, 59:125-133
45. Latham TE, Theophilus BD, Grabowski GA, Smith FI: Heterogeneity of mutations in the acid β-glucosidase gene of Gaucher disease patients. DNA Cell Biol 1991, 10:15-21